Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UCB | Brussels | Healthcare | Pharmaceuticals | €48.26B | 36.6x | 0.08 | €254 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.9% Downside | Upgrade to Pro+ | |
Argen-X | Brussels | Healthcare | Biotechnology & Medical Research | €43.34B | 44.3x | 0.06 | €706.60 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
Tubize-Fin | Brussels | Healthcare | Pharmaceuticals | €10.50B | 114.2x | €235.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | ||
Fagron | Brussels | Healthcare | Pharmaceuticals | €1.51B | 17.6x | 1.87 | €20.60 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
Ion Beam Applications | Brussels | Healthcare | Healthcare Equipment & Supplies | €335.98M | €11.48 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ONWARD Medical BV | Brussels | Healthcare | Healthcare Equipment & Supplies | €235.49M | -6.8x | -0.2 | €5.54 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyxoah | Brussels | Healthcare | Healthcare Equipment & Supplies | €190.73M | -2.4x | 0.07 | €5.20 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyloris | Brussels | Healthcare | Pharmaceuticals | €162.96M | -24.4x | -0.55 | €5.74 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGFA Gevaert | Brussels | Healthcare | Healthcare Equipment & Supplies | €130.05M | -2.1x | 0.03 | €0.84 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sequana Medical | Brussels | Healthcare | Biotechnology & Medical Research | €48.32M | -0.7x | 0.04 | €0.79 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biocartis Group NV | Brussels | Healthcare | Healthcare Equipment & Supplies | €27.24M | 1.5x | €0.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
European Medical Solutions | Brussels | Healthcare | Healthcare Providers & Services | €20.31M | 17.3x | 0.09 | €4.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celyad | Brussels | Healthcare | Biotechnology & Medical Research | €10.74M | -1.6x | -0.07 | €0.25 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosenic | Brussels | Healthcare | Pharmaceuticals | €1.63M | -0.1x | €0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oxurion | Brussels | Healthcare | Biotechnology & Medical Research | €775.81K | 0x | €0.02 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Personalized Nursing Services | Brussels | Healthcare | Healthcare Providers & Services | €245K | €0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |